Cargando…
Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50‐mg Film‐Coated Tablet
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093258/ https://www.ncbi.nlm.nih.gov/pubmed/27274002 http://dx.doi.org/10.1002/cpdd.275 |
_version_ | 1783347670239150080 |
---|---|
author | Otoul, Christian Watanabe, Shikiko McCabe, Suzanne Stockis, Armel |
author_facet | Otoul, Christian Watanabe, Shikiko McCabe, Suzanne Stockis, Armel |
author_sort | Otoul, Christian |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6093258 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60932582018-08-20 Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50‐mg Film‐Coated Tablet Otoul, Christian Watanabe, Shikiko McCabe, Suzanne Stockis, Armel Clin Pharmacol Drug Dev Brief Report John Wiley and Sons Inc. 2016-06-28 2017 /pmc/articles/PMC6093258/ /pubmed/27274002 http://dx.doi.org/10.1002/cpdd.275 Text en © 2016, The Authors. Clinical Pharmacology in Drug Development Published by Wiley Periodicals, Inc. on behalf of The American College of Clinical Pharmacology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Brief Report Otoul, Christian Watanabe, Shikiko McCabe, Suzanne Stockis, Armel Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50‐mg Film‐Coated Tablet |
title | Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50‐mg Film‐Coated Tablet |
title_full | Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50‐mg Film‐Coated Tablet |
title_fullStr | Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50‐mg Film‐Coated Tablet |
title_full_unstemmed | Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50‐mg Film‐Coated Tablet |
title_short | Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50‐mg Film‐Coated Tablet |
title_sort | relative bioavailability and bioequivalence of brivaracetam 10 mg/ml oral solution and 50‐mg film‐coated tablet |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093258/ https://www.ncbi.nlm.nih.gov/pubmed/27274002 http://dx.doi.org/10.1002/cpdd.275 |
work_keys_str_mv | AT otoulchristian relativebioavailabilityandbioequivalenceofbrivaracetam10mgmloralsolutionand50mgfilmcoatedtablet AT watanabeshikiko relativebioavailabilityandbioequivalenceofbrivaracetam10mgmloralsolutionand50mgfilmcoatedtablet AT mccabesuzanne relativebioavailabilityandbioequivalenceofbrivaracetam10mgmloralsolutionand50mgfilmcoatedtablet AT stockisarmel relativebioavailabilityandbioequivalenceofbrivaracetam10mgmloralsolutionand50mgfilmcoatedtablet |